Johnson & Johnson subsidiary Acclarent recently settled its False Claims Act allegations for a record $18 million. The whistleblower lawsuit stated that the company illegally marketed its medical device, the Stratus, to healthcare providers.
Manufactured to treat non-small cell lung cancer, Tarceva manufacturers exaggerated information about the drug’s uses. Some of the inflated lacked research and evidence. After a whistleblower lawsuit was filed, the case was further investigated. The total legal settlement of $67 million will rectify the manufacturer’s false claim allegations and kickbacks to physicians.
After numerous defective saline syringes sickened hundreds of patients, allegations began piling up against B. Braun Medical Group for distributing the devices. To resolve criminal charges brought against it, the company will pay $7.8 million – $3 million to victims and $4.8 million in penalties and forfeited profit.